In the 2016 WHO classification, this category has been eliminated and replaced by the category “high-grade B cell lymphoma, with MYC and BCL-2 and/or BCL-6 rearrangements”, which encompasses “double” and “triple-hit” lymphomas. The gene discussed is BCL2; the disease is lymphoma.